GUZZO ANTHONY J. (VP, Chief Accounting Officer) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/21/2022ACC: 0001209191-22-004492
Officer· VP, Chief Accounting Officer
Since Jun 2021
+36K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
36K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
250.1%
1/19/2022
2.40K→8.40K
Total
Net shares
+6K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2022 | A · Award | +6K | — | — | 250.1% | 2.40K | 8.40K |
| Total | +6K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
+30K
Strike price
15.21
Held after
30K
Exercisable
—
1/19/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30K shares | 1/19/2022 | A · Award | +30K | 15.21 | — | 30K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned463.55
Total
463.55 indirect463.55
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 463.55 | Indirect |
| Total | 463.55 | 463.55 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported